| [1] |
Saklayen MG. The Global Epidemic of the Metabolic Syndrome [J]. Curr Hypertens Rep, 2018, 20(2): 12-20.
|
| [2] |
Uzunlulu M, Telci Caklili O, Oguz A. Association between Metabolic Syndrome and Cancer [J]. Ann Nutr Metab, 2016, 68(3): 173-179.
|
| [3] |
Bishehsari F, Voigt RM, Keshavarzian A. Circadian rhythms and the gut microbiota: from the metabolic syndrome to cancer [J]. Nat Rev Endocrinol, 2020, 16(12): 731-739.
|
| [4] |
O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies [J]. Obes Rev, 2015 Jan, 16(1): 1-12.
|
| [5] |
Siegel RL, Miller KD, Fuchs HE, et al. Cancer Statistics, 2021 [J]. CA Cancer J Clin, 2021, 71(1): 7-33.
|
| [6] |
O'Sullivan DE, Sutherland RL, Town S, et al. Risk Factors for Early-Onset Colorectal Cancer: A Systematic Review and Meta-analysis [J]. Clin Gastroenterol Hepatol, 2022, 20(6): 1229-1240.
|
| [7] |
Chen H, Zheng X, Zong X, et al. Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer [J]. Gut, 2021, 70(6): 1147-1154.
|
| [8] |
Plyasova AA, Berrino E, Khan II, et al. Mechanisms of the Antiproliferative and Antitumor Activity of Novel Telomerase-Carbonic Anhydrase Dual-Hybrid Inhibitors [J]. J Med Chem, 2021, 64(15): 11432-11444.
|
| [9] |
中华医学会糖尿病学分会代谢综合征研究协作组. 中华医学会糖尿病学分会关于代谢综合征的建议 [J]. 中华糖尿病杂志, 2004, (3): 5-10.
|
| [10] |
Lin C, Zhang Y, Chen Y, et al. Long noncoding RNA LINC01234 promotes serine hydroxymethyl-transferase 2 expression and proliferation by competitively binding miR-642a-5p in colon cancer [J]. Cell Death Dis, 2019, 10(2): 137-153.
|
| [11] |
Fernández-Marcelo T, Gómez A, Pascua I, et al. Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status [J]. J Exp Clin Cancer Res, 2015, 34(1): 78-85.
|
| [12] |
Hirode G, Wong RJ. Trends in the prevalence of metabolic syndrome in the United States, 2011-2016 [J]. JAMA, 2020, 323(24): 2526-2528.
|
| [13] |
Bull CJ, Bell JA, Murphy N, et al. Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study [J]. BMC Med, 2020, 18(1): 396-412.
|
| [14] |
Kyrgiou M, Kalliala I, Markozannes G, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature [J]. BMJ, 2017, 356: 477-487.
|
| [15] |
Battelli MG, Bortolotti M, Polito L, et al. Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase [J]. Redox Biol, 2019, 21: 101070-101076.
|
| [16] |
Livingstone J, Shiah YJ, Yamaguchi TN, et al. The telomere length landscape of prostate cancer [J]. Nat Commun, 2021, 12(1): 6893-6906.
|
| [17] |
Tomasova K, Kroupa M, Forsti A,et al.Telomere maintenance in interplay with DNA repair in pathogenesis and treatment of colorectal cancer [J]. Mutagenesis, 2020, 35(3): 261-271.
|
| [18] |
Maciejowski J, de Lange T. Telomeres in cancer: tumour suppression and genome instability [J]. Nat Rev Mol Cell Biol, 2017, 18(3): 175-186.
|
| [19] |
Roger L, Jones RE, Heppel NH, et al. Extensive telomere erosion in the initiation of colorectal adenomas and its association with chromosomal instability [J]. J Natl Cancer Inst, 2013, 105(16): 1202-1211.
|
| [20] |
Mundstock E, Sarria EE, Zatti H, et al. Effect of obesity on telomere length: Systematic review and meta-analysis [J]. Obesity (Silver Spring), 2015, 23(11): 2165-2174.
|